Cargando…
Selenium Supplementation and Prostate Health in a New Zealand Cohort
Background: There is variable reporting on the benefits of a 200 μg/d selenium supplementation towards reducing prostate cancer impacts. The current analysis is to understand whether stratified groups receive supplementation benefits on prostate health. Methods: 572 men were supplemented with 200 µg...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019779/ https://www.ncbi.nlm.nih.gov/pubmed/31861307 http://dx.doi.org/10.3390/nu12010002 |
_version_ | 1783497598310547456 |
---|---|
author | Karunasinghe, Nishi Ng, Lance Wang, Alice Vaidyanathan, Venkatesh Zhu, Shuotun Ferguson, Lynnette R. |
author_facet | Karunasinghe, Nishi Ng, Lance Wang, Alice Vaidyanathan, Venkatesh Zhu, Shuotun Ferguson, Lynnette R. |
author_sort | Karunasinghe, Nishi |
collection | PubMed |
description | Background: There is variable reporting on the benefits of a 200 μg/d selenium supplementation towards reducing prostate cancer impacts. The current analysis is to understand whether stratified groups receive supplementation benefits on prostate health. Methods: 572 men were supplemented with 200 µg/d selenium as selinized yeast for six months, and 481 completed the protocol. Selenium and prostate-specific antigen (PSA) levels were measured in serum at pre- and post-supplementation. Changes in selenium and PSA levels subsequent to supplementation were assessed with and without demographic, lifestyle, genetic and dietary stratifications. Results: The post-supplementation selenium (p = 0.002) and the gain in selenium (p < 0.0001) by supplementation were significantly dependent on the baseline selenium level. Overall, there was no significant correlation between changes in PSA and changes in selenium levels by supplementation. However, stratified analyses showed a significant inverse correlation between changes in PSA and changes in selenium in men below the median age (p = 0.048), never-smokers (p = 0.031), men carrying the GPX1 rs1050450 T allele (CT, p = 0.022 and TT, p = 0.011), dietary intakes above the recommended daily intake (RDI) for zinc (p < 0.05), and below the RDI for vitamin B12 (p < 0.001). Conclusions: The current analysis shows the influence of life factors on prostate health benefits of supplemental selenium. |
format | Online Article Text |
id | pubmed-7019779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70197792020-03-09 Selenium Supplementation and Prostate Health in a New Zealand Cohort Karunasinghe, Nishi Ng, Lance Wang, Alice Vaidyanathan, Venkatesh Zhu, Shuotun Ferguson, Lynnette R. Nutrients Article Background: There is variable reporting on the benefits of a 200 μg/d selenium supplementation towards reducing prostate cancer impacts. The current analysis is to understand whether stratified groups receive supplementation benefits on prostate health. Methods: 572 men were supplemented with 200 µg/d selenium as selinized yeast for six months, and 481 completed the protocol. Selenium and prostate-specific antigen (PSA) levels were measured in serum at pre- and post-supplementation. Changes in selenium and PSA levels subsequent to supplementation were assessed with and without demographic, lifestyle, genetic and dietary stratifications. Results: The post-supplementation selenium (p = 0.002) and the gain in selenium (p < 0.0001) by supplementation were significantly dependent on the baseline selenium level. Overall, there was no significant correlation between changes in PSA and changes in selenium levels by supplementation. However, stratified analyses showed a significant inverse correlation between changes in PSA and changes in selenium in men below the median age (p = 0.048), never-smokers (p = 0.031), men carrying the GPX1 rs1050450 T allele (CT, p = 0.022 and TT, p = 0.011), dietary intakes above the recommended daily intake (RDI) for zinc (p < 0.05), and below the RDI for vitamin B12 (p < 0.001). Conclusions: The current analysis shows the influence of life factors on prostate health benefits of supplemental selenium. MDPI 2019-12-18 /pmc/articles/PMC7019779/ /pubmed/31861307 http://dx.doi.org/10.3390/nu12010002 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karunasinghe, Nishi Ng, Lance Wang, Alice Vaidyanathan, Venkatesh Zhu, Shuotun Ferguson, Lynnette R. Selenium Supplementation and Prostate Health in a New Zealand Cohort |
title | Selenium Supplementation and Prostate Health in a New Zealand Cohort |
title_full | Selenium Supplementation and Prostate Health in a New Zealand Cohort |
title_fullStr | Selenium Supplementation and Prostate Health in a New Zealand Cohort |
title_full_unstemmed | Selenium Supplementation and Prostate Health in a New Zealand Cohort |
title_short | Selenium Supplementation and Prostate Health in a New Zealand Cohort |
title_sort | selenium supplementation and prostate health in a new zealand cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019779/ https://www.ncbi.nlm.nih.gov/pubmed/31861307 http://dx.doi.org/10.3390/nu12010002 |
work_keys_str_mv | AT karunasinghenishi seleniumsupplementationandprostatehealthinanewzealandcohort AT nglance seleniumsupplementationandprostatehealthinanewzealandcohort AT wangalice seleniumsupplementationandprostatehealthinanewzealandcohort AT vaidyanathanvenkatesh seleniumsupplementationandprostatehealthinanewzealandcohort AT zhushuotun seleniumsupplementationandprostatehealthinanewzealandcohort AT fergusonlynnetter seleniumsupplementationandprostatehealthinanewzealandcohort |